Passage BIO (PASG) Current Leases (2022 - 2026)
Passage BIO (PASG) posted quarterly Current Leases of $1.1 million for Q1 2026, down 68.44% year-over-year from $3.6 million in Q1 2025, and down 67.79% quarter-over-quarter from $3.6 million in Q4 2025.
Passage BIO (PASG) Current Leases (2022 - 2026) Analysis & Trends
Passage BIO's Current Leases history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Leases fell 68.44% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 68.44% YoY), while the FY2025 annual figure was $3.6 million, down 3.28% from the prior year.
- Current Leases for Q1 2026 stood at $1.1 million, down from $3.6 million in the prior quarter.
- The five-year high for Current Leases was $3.7 million in Q3 2024, with the low at $1.1 million in Q1 2026.
- The 5-year median for Current Leases is $3.4 million (2023), against an average of $3.3 million.
- The sharpest annual moves came in 2024 and 2026: Current Leases climbed 11.47% in 2024, then tumbled 68.44% in 2026.
- Passage BIO's Current Leases stood at $3.3 million in 2022, then increased by 2.99% to $3.4 million in 2023, then gained by 9.34% to $3.7 million in 2024, then declined by 3.28% to $3.6 million in 2025, then slumped by 67.79% to $1.1 million in 2026.
- Business Quant data shows PASG's Current Leases at $1.1 million in Q1 2026, $3.6 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | Passage BIO | 15.16 Mn | 15.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 3.37 Mn |
| Sep 30, 2023 | 3.35 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.12 Mn |